首页 > 市场调查报告书 > 製药

疼痛

偏头痛治疗市场：按治疗药物、给药途径、地区 - 规模、份额、前景和机会分析，2022-2028 年

市场调查报告书

商品编码

1213876

偏头痛治疗市场：按治疗药物、给药途径、地区 - 规模、份额、前景和机会分析，2022-2028 年

Migraine Therapeutic Market, By Therapeutics, By Route of Administration, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日期: 2023年01月19日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格

简介目录

偏头痛是一种神经系统症状，通常被描述为头部某一部位出现强烈的抽动性或抽动性疼痛。疼痛通常是单侧的、搏动性的，并且通常随着运动而加重。偏头痛是一种头痛，往往会引起其他体征和症状，例如噁心和视力模糊。目前还没有治愈偏头痛的方法，但药物可以预防、停止或使症状恶化。

市场动态：

偏头痛患病率的增加、对安全有效治疗的需求不断增加、人们对偏头痛及其治疗的认识不断提高以及全球研究和开发的不断增加将是全球偏头痛增长的主要因素。头痛药物市场。例如，偏头痛是一种严重且常见的神经系统疾病，严重影响生活质量。 2020 年，偏头痛被世界卫生组织列为因残疾损失年数最多的神经系统疾病。

2022年2月，Biohaven Pharmaceutical Holding Co., Ltd.和辉瑞宣布，欧洲药品管理局（EMA）人用药品委员会通过了对rimegepant的肯定意见。该药物以 75 mg 的 rimegepant 剂量用于成人有或无先兆偏头痛的急性治疗，以及每月偏头痛发作 4 次或以上的成人持续性偏头痛的预防性治疗。（以口服溶解片剂形式销售） ).

这项研究的主要特点

本报告对全球偏头痛药物市场进行了深入分析，提供了以 2021 年为基准年的预测期（2022-2028 年）的市场规模和復合年增长率 (CAGR%) 增长情况。
它还揭示了不同细分市场的潜在创收机会，并为市场勾勒出一个有吸引力的投资建议矩阵。
它还提供了有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争战略等方面的重要见解。
它根据以下参数介绍了全球偏头痛治疗市场的主要参与者，包括公司亮点、产品组合、主要亮点、财务业绩和战略。
本研究涵盖的主要公司包括辉瑞公司、诺华国际公司、默克公司、葛兰素史克公司、礼来公司、阿斯利康公司、安进公司、艾尔建公司、博士伦保健公司., 和 Teva Pharmaceutical Industries Ltd. 等。
这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。我猜。
本研究报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
利益相关者可以通过用于分析全球偏头痛治疗市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

调查目的
先决条件
缩写说明

第二章市场展望

报告内容
- 市场定义和范围
执行摘要
- 按治疗剂分类的市场概况
- 按给药途径划分的市场概况
- 市场概况：按地区
连贯机会图 (COM)

第 3 章市场动态、法规和趋势分析

市场动态
- 全球偏头痛患病率不断上升
- 药物副作用和未确诊病例增加
- 对安全有效治疗的需求不断增长
影响分析
主要亮点
监管情景
产品发布/批准
害虫分析
对 PORTER 的分析
合併/收购场景

第 4 章全球偏头痛药物市场 - 冠状病毒 (COVID-19) 大流行的影响

COVID-19 的流行病学特征
供应方和需求方分析
经济影响

第 5 章全球偏头痛药物市场：按药物分类，2017-2028

止痛药
预防医学

第 6 章全球偏头痛药物市场：按给药途径，2017-2028

口腔/鼻腔
注射

第 7 章全球偏头痛治疗市场：按地区划分，2017-2028

北美
欧洲
亚太地区
拉丁美洲
中东和非洲
世界其他地方

第八章竞争格局

Pfizer Inc.
Novartis International AG
Merck & Co. Inc.
GlaxoSmithKline PLC
Eli Lilly and Company
AstraZeneca PLC
Amgen Inc.
Allergan Inc.
Bausch Health Companies Inc.
Teva Pharmaceutical Industries Ltd.

第 9 章

调查方法
关于出版商

简介目录

Product Code: CMI575

Migraine is a neurological disorder often described as intense pulsing or throbbing pain in one area of the head. The pain is often unilateral and pulsating in nature, which can often be worsened by physical activity. Migraines are a type of headache that tend to cause other signs and symptoms, too, such as nausea and vision problems. There's no cure for migraines yet, but medicines can help prevent or stop them, or keep signs and symptoms from getting worse.

Market Dynamics:

Increase in prevalence of migraine, increase in demand for safe and effective treatment, increase in awareness about migraine and its treatment options, and rise in research and development across the world are major factors expected to propel the growth of the global migraine therapeutic market during the forecast period. For instance, migraine is a serious and common neurological condition with a serious impact on quality of life. In 2020, migraine has been ranked by WHO as the most prevalent neurological condition causing the highest loss of years due to disability.

In February 2022, Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. reported that the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) adopted a positive opinion for Rimegepant. It is recommended as the 75 mg dose of Rimegepant (available as an orally dissolving tablet) for marketing authorization for both the acute treatment of migraine with or without aura in adults and the preventive treatment of episodic migraine in adults who have at least four migraine attacks per month.

Key features of the study:

This report provides in-depth analysis of the global migraine therapeutic market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global migraine therapeutic market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Pfizer Inc., Novartis International AG, Merck & Co. Inc., GlaxoSmithKline PLC, Eli Lilly and Company, AstraZeneca PLC, Amgen Inc., Allergan Inc., Bausch Health Companies Inc., and Teva Pharmaceutical Industries Ltd., among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global migraine therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global migraine therapeutic market.

Detailed Segmentation:

Global Migraine Therapeutic Market, By Therapeutics:
- Pain-relieving Medications
- Preventive Medications
Global Migraine Therapeutic Market, By Route of Administration:
- Oral and Nasal
- Injection
Global Migraine Therapeutic Market, By Geography:
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
Company Profiles:
- Pfizer Inc.
- Novartis International AG
- Merck & Co. Inc.
- GlaxoSmithKline PLC
- Eli Lilly and Company
- AstraZeneca PLC
- Amgen Inc.
- Allergan Inc.
- Bausch Health Companies Inc.
- Teva Pharmaceutical Industries Ltd.

Market Dynamics
- Increase in prevalence of migraine around the world
- Adverse effects of drugs and increasing undiagnosed cases
- Increase in demand for safe and effective treatment
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Migraine Therapeutic Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Migraine Therapeutic Market, By Therapeutics, 2017-2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Pain-relieving Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Preventive Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Migraine Therapeutic Market, By Route of Administration, 2017-2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Oral and Nasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Global Migraine Therapeutic Market, By Geography, 2017-2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Rest of World
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

8. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis International AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co. Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Allergan Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bausch Health Companies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views